(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GELWEAVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GELWEAVE

ST13

US500000079144456

Class

10

Filing

79144456

Registration

4705768

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

03/22/2026

Trademark type

Word

Nice classes

10

Filing date

01/17/2014

Registration date

03/24/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/09/2025

Last transaction

03/22/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

11

Owner location

Renfrewshire, GB

Examiner

MICHELI, ANGELA M

Current location

Historical data usage

Holders and representatives

Holders

Vascutek Limited
Vascutek Limited

Representatives

Megan E. Fink Bodman PLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Surgical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments for treating cardiovascular disease; prosthetic vascular graftsprosthetic endovascular graftsstentsvascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissuecardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; implantable medical systemscardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic vascular graftsprosthetic endovascular graftscatheters; implantable medical devicesimplants consisting of prosthetic materialssynthetic vascular prosthesesprosthetic vascular graftssynthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materialsprosthetic vascular graftsvascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular proceduresmedical devices for use in treating cardiovascular disease; thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems and devices comprising components of more than one stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent graftsstent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent graftsmedical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent graftsstent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systemsprosthetic cardiac valves; heart valvesprosthetic heart valves; heart valve conduitscatheters for implanting heart valves; cardiac patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; vascular patchescardiovascular patchespericardial patchescarotid patchessurgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Publications

History of USPTO decisions and trademark events.

52 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/20/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/20/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/20/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/20/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/20/2026

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

02/09/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/09/2025

71AG

REGISTERED-SEC.71 ACCEPTED

06/09/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/02/2025

ES71

TEAS SECTION 71 RECEIVED

02/06/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

03/24/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/22/2024

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

03/22/2021

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

03/22/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/22/2021

ES75

TEAS SECTION 71 & 15 RECEIVED

02/18/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/24/2020

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/04/2016

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/27/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/15/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/30/2015

FIMP

FINAL DISPOSITION PROCESSED

07/30/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/24/2015

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/27/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/22/2015

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/08/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2015

CHPN

POST PUBLICATION AMENDMENT – NOT ENTERED

03/07/2015

APET

ASSIGNED TO PETITION STAFF

03/06/2015

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

02/19/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/06/2015

PUBO

PUBLISHED FOR OPPOSITION

01/06/2015

GPNX

NOTIFICATION PROCESSED BY IB

01/03/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/17/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/17/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/17/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/04/2014

ALIE

ASSIGNED TO LIE

11/25/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/07/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/01/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/31/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/31/2014

RFNP

REFUSAL PROCESSED BY IB

05/23/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/01/2014

RFRR

REFUSAL PROCESSED BY MPU

04/30/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/30/2014

CNRT

NON-FINAL ACTION WRITTEN

04/29/2014

DOCK

ASSIGNED TO EXAMINER

04/22/2014

MAFR

APPLICATION FILING RECEIPT MAILED

04/01/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/28/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/27/2014

Continuous trademark protection

Get notified about every new filing that threatens GELWEAVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.